" /> inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen - CISMeF





Preferred Label : inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen;

LOINC status : ACTIVE;

LOINC display name : inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript Molgen (Bld/Tiss) [# ratio];

LOINC long common name : inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method;

LOINC short name : inv(16)(p13;q22)/control Bld/T;

LOINC description : A pericentric inversion of chromosome 16, inv(16)(p13;q22), results in a fused transcript between MYH11 (16p13.1) and CBFB (16q22.1) genes and is known to cause acute myeloid leukemia (AML). Techniques like real-time PCR are used to detect the MYH11-CBFB fused transcript. An endogenous control gene transcript (e.g. ABL1, GUS or BCR) is amplified along with the fusion transcript of interest. Standard curves of known amounts of both the control and fusion transcript are used to calculate the ratio of the fusion transcript signal to the control gene signal.;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
08/07/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.